Tuberculina Ppd Rt 23 Ajv

Tuberculin PPD RT 23 Ajv is an intradermal tuberculin test solution used for screening tuberculosis exposure. This purified protein derivative (PPD) helps assess immune response to Mycobacterium tuberculosis. Suitable for Mantoux testing in clinical or occupational screening settings.

Tuberculin PPD RT 23 Ajv is primarily used to detect latent tuberculosis infection (LTBI) through intradermal skin testing. It helps identify individuals who may have been exposed to tuberculosis bacteria, guiding further medical evaluation. The test is commonly used in public health programs, workplace screenings, and pre-employment medical assessments.

When administered intradermally, Tuberculin PPD RT 23 Ajv triggers a localized immune response in individuals sensitized to tuberculosis antigens. This reaction typically appears as a raised area or induration at the injection site within 48–72 hours. The size of the reaction is measured to determine the likelihood of tuberculosis exposure.

Store Tuberculin PPD RT 23 Ajv refrigerated between 2°C and 8°C (36°F and 46°F) and protect from light. Avoid freezing or exposure to extreme temperatures. Discard any unused solution after opening. Use sterile technique during administration to prevent contamination. Do not use if the solution is discolored or contains particles.

No known drug interactions have been reported with Tuberculin PPD RT 23 Ajv. However, recent live virus vaccinations (e.g., measles, mumps, rubella) may temporarily reduce skin test reactivity. Corticosteroids or immunosuppressants could also affect the immune response to the test. Always inform healthcare providers of recent medications or vaccinations.